MRI guidance during treatment for pancreas or liver cancers
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial studies using MRI scans to guide radiation therapy for locally advanced pancreas cancer or liver cancer. It may help make radiation planning more precise, either to control the cancer or to ease symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- Have locally advanced pancreatic cancer or liver cancer (hepatocellular carcinoma)
- Be planning radiation treatment with chemotherapy (chemo-radiation) or a longer radiation plan (including SBRT)
- Your radiation treatment must be scheduled for at least 5 treatment sessions (fractions)
- Be able to safely have an MRI scan without certain metal or implant risks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study does repeated MRI (detailed brain/body imaging) while you receive radiation therapy. It aims to see how these serial scans relate to treatment and outcomes, which could help improve care planning for different cancers.
This study tests if a special MRI scan (MRE) can better diagnose pancreatic masses. It may help doctors find and treat pancreatic cancer more accurately.
This study tests a type of high-precision radiation guided by MRI pictures to treat certain cancers. It may help doctors deliver radiation more accurately while avoiding nearby healthy tissue, but you must be able to safely complete an MRI scan and meet tumor-size and health requirements.
This trial studies using MRI images to help plan and guide radiation therapy after breast-conserving surgery. It may help doctors target the right area more accurately while keeping treatment standard and safe.
This trial studies whether adding an MRI scan improves the selection of people with pancreatic cancer who may benefit from surgery. It focuses on patients without liver spread and with tumors that are borderline or likely removable.
This trial tests a higher dose of radiation guided by MRI for people with pancreatic cancer that cannot be removed by surgery or is borderline removable. It aims to improve treatment effectiveness after initial chemotherapy.
Hear when a new Magnetic Resonance Imaging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.